PLAY PODCASTS
Lessons From Lockdown: HCC and Liver Transplant Care in the COVID-19 Era
Episode 150

Lessons From Lockdown: HCC and Liver Transplant Care in the COVID-19 Era

In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and even improving care of patients with HCC or liver transplantation despite the challenges posed by the COVID-19 pandemic.

Decera Clinical Education Infectious Disease Podcast · Graham R Foster FRCP PhD, Paul Y Kwo MD

March 23, 202229m 55s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Graham R. Foster, FRCP, PhD, and Paul Y. Kwo, MD, share lessons learned in the management of HCC and liver transplantation the COVID-19 era, including:

• Global impact of HCC and strategies for maintaining HCC care in the COVID-19 era
• Characteristics of liver transplant recipients in the COVID-19 era
• Impact of COVID-19 pandemic period on liver transplant outcomes
• Impact of liver transplant status on COVID-19 outcomes
• Strategies for providing streamlined care for patients with liver cancer or liver transplantation in the COVID-19 era

Presenters:

Graham R. Foster, FRCP, PhD 
Professor of Hepatology 
The Liver Unit
Consultant Hepatologist 
Queen Mary University of London
London, United Kingdom

Paul Y. Kwo, MD
Professor of Medicine 
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Follow along with the slides at:
https://bit.ly/3HQ6dZ5

Link to full program:  
https://bit.ly/3Bgyd5I


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

pandemic periodalcoholic liver diseaseviral hepatitisultrasound surveillanceunos databaseliver transplant statusglobal burden of hccuk nhsicu admissionalcohol related liver diseaseliver transplant outcomesliver transplant recipientmultidisciplinary tumor boardcovid-19monoclonal antibodieshcccovid-19 mortality in liver transplant recipientsuk national health servicetelemedicineliver transplant